Following the decision of TORAY, a Japanese manufacturer of artificial kidneys, to increase its production capacity in China by a factor of two last year, the Nihon Keizai Shimbun reported on July 11 that China’s demand for artificial kidneys is huge. forecast, major Japanese manufacturer Nipro medical devices (NIPRO) plans to invest about 4 billion yen additional production lines (medical note: the site is located in Hefei, Anhui) to its factory in China's use of the artificial kidney, the so artificial dialysis treatment China's production capacity has doubled.
The report quoted an insider as saying that in response to market expansion, Niplow has set up training centers in four places, including Shanghai and Beijing, to train medical staff responsible for dialysis treatment. It is planned to expand the number of agents selling equipment to hospitals from the current 38 to about 100 in a few years.
According to Nipro, the number of patients with kidney disease who received artificial dialysis in China was about 440,000 in 2016, an increase of 80% over five years ago.
Artificial kidney produced by NIPRO, a large Japanese medical device manufacturer
The head of Niplow said that in China, dialysis treatment is spreading in large cities, but due to insufficient doctors and equipment in the inland areas, many patients cannot receive appropriate treatment. There are about 300,000 dialysis patients in Japan, so we think the number of potential patients in China is quite large. It is expected that dialysis patients will continue to increase at a rate of 10 to 15% per year.
Barrier Mesh,Plastic Fence Mesh,Insect Barrier Netting,Agfabric Insect Netting
Changzhou Satidi Import and Export Co., Ltd. , https://www.guanjiejts.com